As we have pointed out a few times in the past, Tesla’s (NASDAQ:TSLA) product tall tales, especially about Autopilot, have come back to bite the company. Readers can review the following articles for a history of Tesla’s problematic AP2 rollout:
Tesla Autopilot Unveil Portends Bad News At Tesla
California Autonomous Vehicle Data Shows Tesla Is Materially Misleading Its Customers And Investors
Red Flags Galore In Tesla Q4 Earnings
Tesla Has Significant Disclosure Problems Ahead Of Capital Raise
In essence, Tesla has been selling customers a feature set that does not exist. The company has missed several self-imposed deadlines for product delivery and last check does not even have an ETA for the feature set. In our most recent note we suggested that the problem is getting progressively worse and Tesla has a disclosure obligation to investors. We said:
“One of the key challenges in this regard to Tesla is that existing customers may ask for refund of previously purchased products (not just what they paid for AP2.0 feature but potentially what they paid for the car). As the awareness of the problem increases, new potential customers may also be less inclined to purchase products that lack the advertised feature set.”
bonds investment: Nordic American Offshore Ltd(NAO)
Advisors’ Opinion:
- [By Paul Ausick]
Nordic American Offshore Ltd. (NYSE: NAO) dropped nearly 49% Friday, to post a new 52-week low of $1.05 after closing at $2.05 on Thursday. The stock’s 52-week high is $5.69. Volume was more than 100 times the daily average of around 90,000 shares. The company priced a secondary offering of 40 million shares at just $1.25 per share this morning.
- [By Paul Ausick]
Nordic American Offshore Ltd. (NYSE: NAO) dropped about 2.8% Friday, to post a new 52-week low of $1.05 after closing at $1.08 on Thursday. The stock’s 52-week high is $5.69. Volume was about 4 times the daily average of around 490,000 shares. The company had no specific news.
- [By Lisa Levin]
Nordic American Offshore Ltd. (NYSE: NAO) shares dropped 39 percent to $1.245. Nordic American Offshore priced its upsized offering of 40 million shares at $1.25 per share.
bonds investment: Infinity Pharmaceuticals, Inc.(INFI)
Advisors’ Opinion:
- [By Lisa Levin]
In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.
- [By Lisa Levin]
In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.
- [By Lisa Levin]
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.
bonds investment: SunTrust Banks, Inc.(STI)
Advisors’ Opinion:
- [By Ben Levisohn]
We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).
- [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
bonds investment: Moneygram International, Inc.(MGI)
Advisors’ Opinion:
- [By Ben Levisohn]
Western Union (WU) soared to the top of the S&P 500 today after MoneyGram International (MGI) received a bid from Euronet Worldwide (EEFT).
Agence France-Presse/Getty Images
Shares of Western Union gained 3.5% to $20.27 today, while the S&P 500 fell 0.3% to 2,365.45.MoneyGram International surged 25% to $15.77, while Euronet Worldwide advanced 0.3% to $83.22.
- [By Lisa Levin]
Moneygram International Inc (NASDAQ: MGI) shares were also up, gaining 21 percent to $5.74 after the company reported upbeat Q4 earnings.
Equities Trading DOWN
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested shorting small capmoney transfer services stock Moneygram International (NASDAQ: MGI):
bonds investment: CytomX Therapeutics, Inc.(CTMX)
Advisors’ Opinion:
- [By Lisa Levin]
CytomX Therapeutics Inc (NASDAQ: CTMX) shares were also up, gaining 24 percent to $18.89. Bristol-Myers Squibb Co (NYSE: BMY) and CytomX Therapeutics disclosed that they have extended worldwide partnership to discover Probody therapeutics for the treatment of cancer and other diseases.
bonds investment: Oshkosh Corporation(OSK)
Advisors’ Opinion:
- [By Shanthi Rexaline]
The six companies that met the criterion are:
Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
OshkoshOshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.
- [By WWW.THESTREET.COM]
Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said.
- [By Rich Smith]
I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?
No. To the contrary, I like it even more. (About $3 more, in fact).
You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.
This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.
So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.
Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.
